Zuco, V., Pasquali, S., Tortoreto, M., Brich, S., Percio, S., Dagrada, G. P., . . . Zaffaroni, N. (2021). Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: Evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation. J Exp Clin Cancer Res.
Chicago-tyylinen lähdeviittausZuco, Valentina, et al. "Selinexor Versus Doxorubicin in Dedifferentiated Liposarcoma PDXs: Evidence of Greater Activity and Apoptotic Response Dependent On P53 Nuclear Accumulation and Survivin Down‐regulation." J Exp Clin Cancer Res 2021.
MLA-viiteZuco, Valentina, et al. "Selinexor Versus Doxorubicin in Dedifferentiated Liposarcoma PDXs: Evidence of Greater Activity and Apoptotic Response Dependent On P53 Nuclear Accumulation and Survivin Down‐regulation." J Exp Clin Cancer Res 2021.